Panagora Asset Management Inc Evolus, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$7.81 - $11.05 $233,331 - $330,129	-29,876 Reduced 50.18%	29,661 $250,000
Q4 2022 Feb 13, 2023	SELL	$6.52 - $8.95 $101,685 - $139,584	-15,596 Reduced 20.76%	59,537 $447,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $199,261 - $352,302	25,678 Added 51.92%	75,133 $605,000
Q2 2022 Aug 15, 2022	BUY	$10.22 - $13.94 $91 - $125	9 Added 0.02%	49,455 $574,000
Q1 2022 May 12, 2022	BUY	$5.22 - $11.78 $258,108 - $582,473	49,446 New	49,446 $555,000
Q1 2021 May 12, 2021	SELL	$3.2 - $16.51 $1,472 - $7,594	-460 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.03 - $5.48 $1,393 - $2,520	460 New	460 $2,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.